These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 12112049

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sudomotor testing discriminates between subjects with and without antibodies against botulinum toxin A--a preliminary observation.
    Birklein F, Erbguth F.
    Mov Disord; 2000 Jan; 15(1):146-9. PubMed ID: 10634255
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ninhydrin sweat test: a simple method for detecting antibodies neutralizing botulinum toxin type A.
    Voller B, Moraru E, Auff E, Benesch M, Poewe W, Wissel J, Müller J, Entner T, Bigalke H, Schnider P.
    Mov Disord; 2004 Aug; 19(8):943-7. PubMed ID: 15300661
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Botulinum neurotoxin type A in urology: antibodies as a cause of therapy failure.
    Schulte-Baukloh H, Bigalke H, Miller K, Heine G, Pape D, Lehmann J, Knispel HH.
    Int J Urol; 2008 May; 15(5):407-15; discussion 415. PubMed ID: 18452456
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Increased botulinum toxin type A dosage is more effective in patients with Frey's syndrome.
    Guntinas-Lichius O.
    Laryngoscope; 2002 Apr; 112(4):746-9. PubMed ID: 12150533
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Botulinum toxin type B blocks sudomotor function effectively: a 6 month follow up.
    Birklein F, Eisenbarth G, Erbguth F, Winterholler M.
    J Invest Dermatol; 2003 Dec; 121(6):1312-6. PubMed ID: 14675175
    [Abstract] [Full Text] [Related]

  • 16. Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay.
    Brin MF, Comella CL, Jankovic J, Lai F, Naumann M, CD-017 BoNTA Study Group.
    Mov Disord; 2008 Jul 30; 23(10):1353-60. PubMed ID: 18546321
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia.
    Factor SA, Molho ES, Evans S, Feustel PJ.
    Mov Disord; 2005 Sep 30; 20(9):1152-60. PubMed ID: 15954134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.